首页> 外国专利> USE OF ITIH1 AS BIOMARKER FOR DETECTION OF INSULIN RESISTANCE IN DISEASES ACCOMPANIED BY IMPAIRED GLUCOSE TOLERANCE

USE OF ITIH1 AS BIOMARKER FOR DETECTION OF INSULIN RESISTANCE IN DISEASES ACCOMPANIED BY IMPAIRED GLUCOSE TOLERANCE

机译:使用ITIH1作为生物标志物,用于检测伴有葡萄糖耐量受损的疾病中的胰岛素抵抗力

摘要

Disclosed are a composition and method for the diagnosis of diseases accompanied by impaired glucose tolerance, comprising a material for ITIH1 detection. The composition and method according to the present application enable a relatively sensitive response even to small changes in blood sugar according to various stimulants in a hyperglycemic situation as compared to glycated hemoglobin (HbA1c) which is an existing diagnostic marker widely used for patients with diabetes, which is a typical disease accompanied by impaired glucose tolerance, and thus can more precisely detect blood sugar changes under various stress situations.
机译:公开了一种用于诊断伴有葡萄糖耐量受损的疾病的组合物和方法,包括用于ITIH1检测的材料。根据本申请的组合物和方法使得与血糖血红蛋白(HBA1C)相比,均匀血红蛋白(HBA1C)的各种兴奋剂的血糖中的血糖的小变化能够进行相对敏感的反应,这是一种糖尿病患者的现有诊断标志物,这是典型的疾病伴随着葡萄糖耐受性受损,因此可以更精确地检测各种压力情况下的血糖变化。

著录项

  • 公开/公告号WO2021045515A1

    专利类型

  • 公开/公告日2021-03-11

    原文格式PDF

  • 申请/专利权人 APHARMA;

    申请/专利号WO2020KR11814

  • 申请日2020-09-03

  • 分类号G01N33/68;

  • 国家 KR

  • 入库时间 2022-08-24 17:41:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号